Holen Sie sich die Stockscreener-App
168.57
5.15%
-8.61
Schlusskurs vom Vortag:
$177.18
Offen:
$162.93
24-Stunden-Volumen:
6.22M
Relative Volume:
3.88
Marktkapitalisierung:
$28.58B
Einnahmen:
$15.90B
Nettoeinkommen (Verlust:
$1.28B
KGV:
23.14
EPS:
7.2842
Netto-Cashflow:
$2.21B
1W Leistung:
-7.13%
1M Leistung:
-30.23%
6M Leistung:
-9.61%
1J Leistung:
-15.05%
1-Tages-Spanne:
$156.66
$170.00
1-Wochen-Bereich:
$156.66
$194.83
52-Wochen-Spanne:
$134.65
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Firmenname
Iqvia Holdings Inc
Sektor
Branche
Telefon
919-998-2000
Adresse
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
168.51 | 30.05B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
TMO
Thermo Fisher Scientific Inc
|
509.73 | 198.06B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
215.97 | 155.50B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
618.59 | 51.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
125.00 | 36.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
318.71 | 32.29B | 3.11B | 648.81M | 602.27M | 10.88 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-03 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-09 | Hochstufung | Jefferies | Hold → Buy |
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-13 | Eingeleitet | BTIG Research | Buy |
| 2023-11-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-03-17 | Eingeleitet | Truist | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-11-17 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-16 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-07-07 | Eingeleitet | Stephens | Equal-Weight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-12-13 | Hochstufung | CFRA | Sell → Hold |
| 2019-11-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Hochstufung | Mizuho | Neutral → Buy |
| 2019-05-28 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-18 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-09 | Eingeleitet | UBS | Buy |
| 2018-10-02 | Bestätigt | Robert W. Baird | Outperform |
| 2018-07-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Bestätigt | Stifel | Buy |
| 2018-07-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Hochstufung | Goldman | Neutral → Buy |
| 2018-03-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
The Top 5 Analyst Questions From IQVIA's Q4 Earnings Call - Finviz
Earnings growth of 3.6% over 3 years hasn't been enough to translate into positive returns for IQVIA Holdings (NYSE:IQV) shareholders - Yahoo Finance
75,170 Shares in IQVIA Holdings Inc. $IQV Purchased by Eubel Brady & Suttman Asset Management Inc. - MarketBeat
IQVIA Holdings Inc (IQV) Shares Gap Down to $186.065 on Feb 10 - GuruFocus
Global obesity trials get boost from new IQVIA–Duke research pact - Stock Titan
Compagnie Lombard Odier SCmA Cuts Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Aug EndMonth: Is IQVIA Holdings Inc stock influenced by commodity pricesTrade Performance Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
IQVIA revenue for Q4 2025 up 10.3% to USD 4,364M - Medical Buyer
Candriam S.C.A. Grows Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. Stock Outperforms Competitors On Strong Trading Day - Longbridge
IQVIA Expands AI Data Partnerships As Investors Weigh Growth Prospects - Yahoo Finance
Rally Mode: Is Vipshop Holdings Limited Depositary Receipt subject to activist investor interestQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
IQVIA Holdings (IQV) Valuation Check After Profit Guidance Disappoints Despite Solid Quarterly Revenue Beat - Sahm
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Haemonetics (HAE) and Denali Therapeutics (DNLI) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: IQVIA Holdings (IQV) and Molina Healthcare (MOH) - The Globe and Mail
Thrivent Financial for Lutherans Has $5.76 Million Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Envestnet Asset Management Inc. Boosts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Fell 19% This Week. Could Shares Push Toward $260 in 2026? - TIKR.com
Jefferies lowers IQVIA stock price target to $255 on margin pressures By Investing.com - Investing.com South Africa
IQVIA Leans On AI And Boehringer Deal As Shares Struggle - Sahm
IQVIA Q4 Earnings Call Highlights - Yahoo Finance
Jefferies lowers IQVIA stock price target to $255 on margin pressures - Investing.com UK
IQV: JP Morgan Lowers Price Target While Maintaining Overweight Rating | IQV Stock News - GuruFocus
IQVIA stock price target lowered to $225 by Evercore ISI amid AI concerns By Investing.com - Investing.com Australia
UBS Adjusts IQVIA Holdings (IQV) Price Target to $240 Amidst Ste - GuruFocus
Jefferies Lowers Price Target for IQVIA Holdings (IQV) to $255 | - GuruFocus
IQV Analyst Rating Update: Stifel Lowers Price Target to $220 | IQV Stock News - GuruFocus
Barclays Analyst Lowers Price Target for IQV to $210 | IQV Stock News - GuruFocus
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term - Yahoo Finance
Leerink Partners Adjusts Price Target on IQVIA Holdings to $228 From $256, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Price Target on IQVIA Holdings to $225 From $250, Maintains Outperform Rating - marketscreener.com
Barclays Adjusts IQVIA Price Target to $210 From $230, Maintains Equal Weight Rating - marketscreener.com
JPMorgan Adjusts IQVIA Price Target to $225 From $255, Maintains Overweight Rating - marketscreener.com
Citigroup Adjusts IQVIA Price Target to $200 From $230, Maintains Neutral Rating - marketscreener.com
IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis - Finviz
TD Waterhouse Canada Inc. Sells 16,903 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. (NYSE:IQV) Q4 2025 Earnings Call Transcript - Insider Monkey
Jefferies Adjusts Price Target on IQVIA Holdings to $255 From $270, Maintains Buy Rating - marketscreener.com
Stifel Adjusts Price Target on IQVIA Holdings to $220 From $273, Maintains Buy Rating - marketscreener.com
IQVIA stock price target lowered to $225 by Evercore ISI amid AI concerns - Investing.com Nigeria
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Omnicell (OMCL) and MiMedx Group (MDXG) - The Globe and Mail
IQVIA Slipped 1% on AI Pivot: Why the Stock Could Rebound to $303 in 2026? - TIKR.com
Research Alert: CFRA Maintains Buy Rating On Shares Of Iqvia Holdings Inc. - 富途牛牛
IQVIA Q4 2025 slides: Revenue jumps 10.3%, stock falls despite beat - Investing.com Nigeria
IQVIA (IQV) Stock Trades Down, Here Is Why - Finviz
IQVIA Holdings (IQV) Q4 2025 Earnings Call Transcript - Fortune
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y - The Globe and Mail
IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
IQVIA Stock Drops as 2026 Outlook Misses Wall Street Expectations - Blockonomi
IQVIA backs AI strategy as analysts question impact on business - marketscreener.com
Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):